Water Network Perturbation in Ligand Binding: Adenosine A2A Antagonists as a Case Study
暂无分享,去创建一个
Jonathan W. Essex | Michael S. Bodnarchuk | Jonathan S. Mason | Andrea Bortolato | Benjamin G. Tehan | J. Mason | A. Bortolato | J. Essex | B. Tehan | M. S. Bodnarchuk | M. Bodnarchuk
[1] Andrea Bortolato,et al. New insights from structural biology into the druggability of G protein-coupled receptors. , 2012, Trends in pharmacological sciences.
[2] Gabriele Cruciani,et al. A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application , 2007, J. Chem. Inf. Model..
[3] Paul D Lyne,et al. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.
[4] P. Ball. Water as an active constituent in cell biology. , 2008, Chemical reviews.
[5] A. Warshel,et al. Calculations of antibody-antigen interactions: microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603. , 1992, Protein engineering.
[6] K. Kosik,et al. Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.
[7] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[8] N. Vermeulen,et al. The role of water molecules in computational drug design. , 2010, Current topics in medicinal chemistry.
[9] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[10] Robert A Copeland,et al. The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety , 2010, Expert opinion on drug discovery.
[11] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[12] Martin Smiesko,et al. AcquaAlta: A Directional Approach to the Solvation of Ligand-Protein Complexes , 2011, J. Chem. Inf. Model..
[13] Jonathan S. Mason,et al. Progress in Structure Based Drug Design for G Protein-Coupled Receptors , 2011, Journal of medicinal chemistry.
[14] Cristiano Ruch Werneck Guimarães,et al. Addressing Limitations with the MM-GB/SA Scoring Procedure using the WaterMap Method and Free Energy Perturbation Calculations , 2010, J. Chem. Inf. Model..
[15] P. Kollman,et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.
[16] Luísa V. Lopes,et al. Adenosine and related drugs in brain diseases: present and future in clinical trials. , 2011, Current topics in medicinal chemistry.
[17] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[18] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[19] Fumio Hirata,et al. Placevent: An algorithm for prediction of explicit solvent atom distribution—Application to HIV‐1 protease and F‐ATP synthase , 2012, J. Comput. Chem..
[20] Mei Liu,et al. Prediction of protein-protein interactions using random decision forest framework , 2005, Bioinform..
[21] R. Copeland. Conformational adaptation in drug-target interactions and residence time. , 2011, Future medicinal chemistry.
[22] Julien Michel,et al. Prediction of the water content in protein binding sites. , 2009, The journal of physical chemistry. B.
[23] Woody Sherman,et al. New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap , 2010, Proteins.
[24] R. Copeland,et al. Drug–target residence time and its implications for lead optimization , 2007, Nature Reviews Drug Discovery.
[25] Fumio Hirata,et al. Locating missing water molecules in protein cavities by the three‐dimensional reference interaction site model theory of molecular solvation , 2006, Proteins.
[26] Loriano Storchi,et al. New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..
[27] C. Tate,et al. Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor , 2011, Journal of molecular biology.
[28] C. Higgs,et al. Hydration Site Thermodynamics Explain SARs for Triazolylpurines Analogues Binding to the A2A Receptor. , 2010, ACS medicinal chemistry letters.
[29] Lingle Wang,et al. Ligand binding to protein-binding pockets with wet and dry regions , 2011, Proceedings of the National Academy of Sciences.
[30] Pál Pacher,et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.
[31] K. Palczewski,et al. Role of Bulk Water in Hydrolysis of the Rhodopsin Chromophore* , 2011, The Journal of Biological Chemistry.
[32] K A Dill,et al. Additivity Principles in Biochemistry* , 1997, The Journal of Biological Chemistry.
[33] Loriano Storchi,et al. Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases , 2009, J. Chem. Inf. Model..
[34] Felice C. Lightstone,et al. Accounting for water molecules in drug design , 2011, Expert opinion on drug discovery.
[35] Leonardo Pardo,et al. The Role of Internal Water Molecules in the Structure and Function of the Rhodopsin Family of G Protein‐Coupled Receptors , 2007, Chembiochem : a European journal of chemical biology.
[36] Nathan Robertson,et al. Biophysical Mapping of the Adenosine A2A Receptor , 2011, Journal of medicinal chemistry.
[37] Albert C. Pan,et al. Molecular determinants of drug-receptor binding kinetics. , 2013, Drug discovery today.
[38] Caterina Barillari,et al. Classification of water molecules in protein binding sites. , 2007, Journal of the American Chemical Society.
[39] Woody Sherman,et al. Contributions of water transfer energy to protein‐ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors , 2013, Proteins.
[40] Mihaly Mezei,et al. Simulated Annealing of Chemical Potential: A General Procedure for Locating Bound Waters. Application to the Study of the Differential Hydration Propensities of the Major and Minor Grooves of DNA , 1996 .
[41] Urban Bren,et al. Individual degrees of freedom and the solvation properties of water. , 2012, The Journal of chemical physics.
[42] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[43] John B. O. Mitchell,et al. A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking , 2010, Bioinform..
[44] R. Woods,et al. Involvement of water in carbohydrate-protein binding. , 2001, Journal of the American Chemical Society.
[45] Woody Sherman,et al. Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases , 2011, ChemMedChem.
[46] James E. J. Mills,et al. High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields , 2010, J. Chem. Inf. Model..
[47] Holger Gohlke,et al. Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf , 2004, J. Comput. Chem..
[48] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[49] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[50] Teruki Honma,et al. Combining Machine Learning and Pharmacophore-Based Interaction Fingerprint for in Silico Screening , 2010, J. Chem. Inf. Model..
[51] PatrickY.-S. Lam,et al. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.
[52] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.
[53] Gregory A Ross,et al. Rapid and Accurate Prediction and Scoring of Water Molecules in Protein Binding Sites , 2012, PloS one.
[54] Paolo Carnevali,et al. Fragment-Based Computation of Binding Free Energies by Systematic Sampling , 2009, J. Chem. Inf. Model..
[55] D. J. Adams,et al. Chemical potential of hard-sphere fluids by Monte Carlo methods , 1974 .
[56] Helgi B. Schiöth,et al. Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.
[57] Urban Bren,et al. Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method. , 2006, The journal of physical chemistry. B.
[58] K. Jacobson,et al. Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.
[59] Richard A. Friesner,et al. Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide , 2012, Journal of Computer-Aided Molecular Design.
[60] P. Kollman,et al. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .
[61] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[62] F. Micheli,et al. Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial , 2011, The Lancet Neurology.
[63] Klaus R. Liedl,et al. A GRID-Derived Water Network Stabilizes Molecular Dynamics Computer Simulations of a Protease , 2011, J. Chem. Inf. Model..
[64] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[65] Mark R. Chance,et al. Structural waters define a functional channel mediating activation of the GPCR, rhodopsin , 2009, Proceedings of the National Academy of Sciences.
[66] Urban Bren,et al. Do all pieces make a whole? Thiele cumulants and the free energy decomposition , 2007 .
[67] R. Copeland,et al. Residence time of receptor-ligand complexes and its effect on biological function. , 2008, Biochemistry.
[68] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[69] J. Aqvist,et al. A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.
[70] Chris Oostenbrink,et al. Cytochrome P450 3A4 Inhibition by Ketoconazole: Tackling the Problem of Ligand Cooperativity Using Molecular Dynamics Simulations and Free-Energy Calculations , 2012, J. Chem. Inf. Model..
[71] S. Iwata,et al. G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.
[72] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[73] S. Moro,et al. The ATP‐Binding Site of Protein Kinase CK2 Holds a Positive Electrostatic Area and Conserved Water Molecules , 2007, Chembiochem : a European journal of chemical biology.
[74] Benoît Roux,et al. Grand canonical Monte Carlo simulations of water in protein environments. , 2004, The Journal of chemical physics.
[75] B. Berne,et al. Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. , 2008, Journal of the American Chemical Society.
[76] Urban Bren,et al. DNA duplex stability: the role of preorganized electrostatics. , 2010, The journal of physical chemistry. B.
[77] Stefano Moro,et al. In Silico Binding Free Energy Predictability by Using the Linear Interaction Energy (LIE) Method: Bromobenzimidazole CK2 Inhibitors as a Case Study , 2007, J. Chem. Inf. Model..
[78] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[79] Ricardo L Mancera. Molecular modeling of hydration in drug design. , 2007, Current opinion in drug discovery & development.
[80] Nathan Robertson,et al. Article pubs.acs.org/jmc Identification of Novel Adenosine A 2A Receptor Antagonists by Virtual Screening , 2022 .
[81] M. Congreve,et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.
[82] Jonathan S. Mason,et al. Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design , 2012, Journal of medicinal chemistry.
[83] F. J. Luque,et al. Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design. , 2011, Journal of the American Chemical Society.